Geron Stock – Class Action Filed Against Geron Corporation – GERN

Kehoe Law Firm, P.C. informs investors that on March 13, 2025, a class action complaint alleging violations of federal securities laws was filed against Geron Corporation (“Geron”) (NASDAQ:GERN) in United States District Court, Northern District of California (Case No. 3:25-cv-02507).

The securities class action lawsuit was filed on behalf of Geron investors who purchased or acquired Geron securities between June 7, 2024, to February 25, 2025, inclusive (the “Class Period”). The lawsuit seeks to recover damages caused by the Geron Defendants’ alleged violations of the federal securities laws.

Investors who Acquired Geron Securities During the Class Period May Have Legal Claims 

Geron investors who acquired their securities during the Class Period are encouraged to complete Kehoe Law Firm’s Stockholder Information Request form or send us a message to contact an attorney to discuss the class action and receive a free, no-obligation evaluation of potential legal claims.

For direct inquiries, Geron investors should contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Profound Medical Corp. – PROF

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Profound Medical Corp. (“Profound Medical,” “Profound,” or the “Company”) (NASDAQ:PROF)

Profound Medical Reports Error Which Overstated Revenue

In a March 7, 2025 Form 8-K, Profound reported that “[i]n conjunction with the Company’s transition to U.S. GAAP, the Audit Committee of Profound’s Board of Directors (the ‘Audit Committee’), after discussion with Profound’s auditors, has identified an error which overstated revenue by $472,000 in the first quarter of 2024. The corrected financial information also increases the U.S. GAAP net loss before tax and net loss attributed to shareholders by $386,000.”

The Company also reported that as a result of their error, “. . . Profound determined . . . that Profound’s previously issued 2024 Interim Financial Statements, each prepared in accordance with International Financial Reporting Standards . . . as filed on SEDAR+, and furnished to the U.S. Securities and Exchange Commission on Form 6-K, will be restated and reissued and should no longer be relied upon.”

As a result of the Company’s error, Profound Medical also reported that “. . . any previously filed or furnished reports, related earnings releases, related management’s discussion and analysis, investor presentations or similar communications of Profound describing Profound’s financial results or other financial information for the quarters of 2024, and any previously issued forecast or guidance for the fiscal year ended December 31, 2024, should no longer be relied upon. Profound’s 2024 Interim Financial Statements will be restated to effect the revenue adjustments described above, as well as other related flow through adjustments.”

On this news, Profound Medical’s stock price dropped almost 6%, closing at $6.86 per share on March 7, 2025.

Profound Medical Investors May Have Legal Claims

Investors of Profound Medical stock who have suffered financial losses are encouraged to complete Kehoe Law Firm’s Stockholder Information Request form or send us a message to contact an attorney to discuss the securities fraud investigation and receive a free, no-obligation legal evaluation.

For direct inquiries, Profound Medical investors should contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Fluence Energy, Inc. Class Action Lawsuit – FLNC

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Fluence Energy, Inc. (“Fluence Energy” or “Fluence”) (NASDAQ:FLNC).

Class Action Complaint Filed Against Fluence Energy 

On March 11, 2025, a class action complaint was filed in United States District Court, Eastern District of Virginia (Case No. 1:25-cv-00444), against Fluence Energy on behalf of investors who purchased or otherwise acquired Fluence common stock between November 29, 2023 to February 10, 2025, both dates inclusive (the “Class Period”). 

Alleged Violations of the Federal Securities Laws

The class action alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, 15 U.S.C. §§ 78j(b) and 78t(a) and Rule 10b-5 promulgated thereunder by the SEC, 17 C.F.R. § 240.10 b-5.

Specifically, throughout the Class Period, the Fluence Defendants allegedly made false and/or misleading statements, as well as failed to disclose material facts, including that:

  • Fluence’s relationship with its founders and largest sources of revenue, Siemens AG and The AES Corporation, was poised to decline;
  • Siemens Energy, Siemens AG’s U.S. affiliate, had accused Fluence of engineering failures and fraud;
  • Fluence Energy’s margins and revenue growth were inflated as Siemens and AES were moving to divest; and
  • Based on the foregoing, the Fluence Energy Defendants lacked a reasonable basis for their positive statements related to Fluence’s battery energy storage business, as well as related financial results, growth, and prospects.

Fluence Energy investors who acquired their Fluence stock during the Class Period are encouraged to complete KLF’s Stockholder Information Request form or send us a message to contact an attorney for a free, no-obligation legal evaluation.

For direct inquiries, Fluence Energy investors should contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

The Bancorp, Inc. – Securities Fraud Investigation – TBBK

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of The Bancorp, Inc. (“The Bancorp,” “Bancorp” or the “Company”) (NASDAQ:TBBK).

Class Action Lawsuit Filed Against The Bancorp

On March 14, 2025, a class action complaint alleging violations of the federal securities laws was filed against The Bancorp in United States District Court for the District of Delaware on behalf of Bancorp investors who purchased or otherwise acquired the Company’s securities between January 25, 2024 and March 4, 2025, both dates inclusive (the “Class Period”). 

Bancorp Investors Who Acquired Their Securities During the Class Period May Have Legal Claims

Bancorp investors who acquired their securities during the Class Period and suffered financial losses are encouraged to complete KLF’s Stockholder Information Request Form or send us a message to contact an attorney for a free, no-obligation legal evaluation.

Summary of the Securities Fraud Class Action Allegations 

According to the complaint, throughout the Class Period, the Bancorp Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.

Specifically, The Bancorp Defendants allegedly failed to disclose to investors that Bancorp had underrepresented the significant risk of default or loss on its REBL loan portfolio; the Company’s current expected credit loss methodology was insufficient to account for the provision and/or allowance of credit losses; and as a result of the foregoing, the Company was reasonably likely to increase its provision for credit losses.

The complaint also alleges that throughout the Class Period, there were material weakness in the Company’s internal control over financial reporting; its financial statements had not been approved by its independent auditor; and as a result, the Company’s financial statements could not be relied upon, and the  Bancorp Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Bancorp Reports It Inappropriately Filed its Annual Report on Form 10-K

On March 4, 2025, The Bancorp reported that “[o]n March 3, 2025, [it] . . . inappropriately filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the ‘Annual Report’).”

The Company reported that “[a]fter receiving notification on March 3, 2025 from the Company’s independent public accounting firm, Crowe LLP, on March 4, 2025, the Audit Committee of the Board of Directors concluded that the Company’s filed financial statements for the fiscal years ended December 31, 2022 through 2024 as shown in the Annual Report, should no longer be relied upon . . ..”

The Bancorp further reported that it “. . . is working expeditiously to perform and complete additional closing procedures related to accounting for consumer fintech loans in the allowance for credit losses and to file an amended Annual Report on Form 10-K/A to issue its financial statements for the fiscal years ended December 31, 2022 through 2024 to include Crowe’s and Grant Thornton LLP’s audit opinions and related consents. The Company is evaluating the impact of this non-reliance on its conclusions regarding disclosure controls and procedures and internal control over financial reporting.”

The Bancorp Continues to Evaluate Its Conclusions Regarding Internal Control Over Financial Reporting

On March 10, 2025, Bancorp reported that it “. . . expects to record an adjustment to the allowance for loan losses and provision expense associated with consumer fintech loans outstanding at the end of the period, and record a like amount, to the consumer fintech loan credit enhancement on the balance sheet and non-interest income, with no net income impact.”

The Company also reported that it “. . . is continuing to evaluate its conclusions regarding disclosure controls and procedures, and internal control over financial reporting.” 

Learn More About The Bancorp Class Action 

For direct inquiries, Bancorp investors who acquired their securities during the Class Period should contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

bluebird bio – BLUE

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of bluebird bio, Inc. (NASDAQ:BLUE) regarding the adequacy and fairness of the proposed acquisition of bluebird bio by “funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners, LP (‘SK Capital’) in collaboration with a team of highly experienced biotech executives.”

On February 21, 2025, bluebird bio announced an agreement to be acquired in a deal bluebird bio said is a “transaction [that] is the only viable solution to generate value for stockholders.”

On this news, bluebird bio’s stock was down more than 38% pre-market on February 21, 2025.  

Obtain More Information About the Securities Investigation 

bluebird bio investors are encouraged to can send us a message or complete Kehoe Law Firm’s Stockholder Information Request form to contact an attorney for a free, no-obligation legal evaluation.

For direct inquiries, bluebird bio shareholders should contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Cardlytics, Inc. – CDLX

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ:CDLX) who purchased or otherwise acquired Cardlytics stock shares between March 14, 2024 and August 7, 2024, inclusive (the “Class Period”).

Cardlytics investors who acquired their stock during the Class Period with losses greater than $50,000 are encouraged to send us a message or complete our Kehoe Law Firm’s Stockholder Information Request form to reach an attorney for a free, no-obligation evaluation of potential legal claims.

Cardlytics Securities Fraud Class Action Lawsuit Allegations

A securities class action lawsuit has been filed against Cardlytics, alleging violations of federal securities laws. The complaint alleges that throughout the Class Period, the Cardlytics defendants failed to disclose material adverse facts to investors, including that increased consumer engagement led to an increase in consumer incentives; the Company was unable to increase billings in line with increased consumer engagement; and, as a result, there was a significant risk of slowing or declining revenue growth; and changes to its Ads Decision Engine (“ADE”) contributed to the “under-delivery” of budgets and customer billing estimates.

Cardlytics Investors: Learn More About Your Legal Rights

Investors with significant losses who acquired Cardlytics stock during the Class Period can contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the securities investigation and receive a free, no-obligation legal evaluation.

Investors have until March 25, 2025 to petition the Court for appointment as lead plaintiff. The Court typically appoints the investor with the largest financial interest who also meets the adequacy and typicality requirements. Shareholders who wish to discuss the lead plaintiff process should contact us.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

 

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]